01875 TOT BIOPHARM-B
Closed Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2024) | |||
| Current | 1.79X | Oper Margin | 4.1% |
|---|---|---|---|
| LT Debt/Equity | 44.5% | Net Margin | 3.2% |
| Total Debt/Equity | 54.2% | Return on Equity | 4.8% |
| Price/Book | 1.89X | Return on Assets | 2.3% |
| (HKD 1.900) | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
| Net Profit (MHKD) | 36.96 | -41.62 | -55.97 | -319.49 | -342.39 |
|---|---|---|---|---|---|
| Net Profit Growth (%) | +188.8 | +25.6 | +82.5 | +6.7 | -2.3 |
| Earnings Per Share (HKD) | 0.051 | -0.057 | -0.088 | -0.557 | -0.6 |
| Earnings Per Share Growth (%) | +188.9 | +34.4 | +84.3 | +7.2 | +39.8 |
| Dividend Per Share (HKD) | No dividend | No dividend | No dividend | No dividend | No dividend |
| P/E* (X) | 37.25 | N/A | N/A | N/A | N/A |
| Yield (%) | N/A | N/A | N/A | N/A | N/A |
| Dividend Share (%) | N/A | N/A | N/A | N/A | N/A |
| Book NAV (HKD) | 1.004 | 0.979 | 1.036 | 0.666 | 1.151 |
| Auditors' Opinion | Unqualified | Unqualified | Unqualified | Unqualified | Unqualified |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2025-07-22 21:40:20
Latest Result
| (RMBMn) | 2024-12 | 2023-12 | Chg* (%) | 2022-12 |
| Cover Period (mths) | 12 | 12 | NA | 12 |
|---|---|---|---|---|
| Turnover | 1,098 | 780.629 | +40.7 | 442.178 |
| Operating Result | 35.691 | -31.841 | -212.1 | -41.054 |
| Associates | 0 | -2.495 | -100.0 | -6.633 |
| Profit Before Taxation | 34.757 | -37.756 | -192.1 | -50.046 |
| Taxation | 0 | 0.001 | -100.0 | 0 |
| Profit /( Loss) After Taxation | 34.757 | -37.757 | -192.1 | -50.046 |
| Minority Interests | 0 | 0 | N/A | -0.13 |
| Net Profit | 34.757 | -37.757 | -192.1 | -49.916 |
| Earnings Per Share () | 0.0510 | -0.0574 | -188.9 | -0.0875 |
| Announcement Date | 2025-03-11 | 2024-03-15 | NA | 2023-03-23 |
* Annualised
Last Update Time: 2025-07-22 21:40:25
